Announcement PDF ASX Announcement 13 July 2020 ASX Market Announcements ASX Limited Level 4 North Tower, Rialto 525 Collins Street Melbourne VIC 3000 2020 Annual General Meeting Results Melbourne, Australia, 13 July 2020 – In accordance with ASX Listing Rule 3.13.2 and section 251AA of the Corporations Act, Avecho Biotechnology Limited (ASX: AVE) advises that the details of the resolutions and the proxies received in respect of each resolution at its Annual General Meeting today are set out in the attached proxy summary. For enquiries, please contact Melanie Leydin Company Secretary +61 3 9692 7222 This announcement has been authorised by the Board of Directors of Avecho Biotechnology Limited. About Avecho Avecho Biotechnology Limited (ASX: AVE) develops and commercialises innovative Human and Animal Health products using its proprietary drug delivery system called TPM®. TPM® is derived from Vitamin E using unique, proprietary and patented processes and is proven to enhance the solubility and oral, dermal and transdermal absorption of drugs and nutrients. Avecho’s major projects include delivering TPM® enhanced injectable, oral and topical products for the human health market and is also developing TPM® to enhance the feed efficiency and health of livestock. New additions to the development program include the recently announced application of TPM® to cannabinoids. See more here - avecho.com.au Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168 avecho.com.au Annual General Meeting Monday 13 July 2020 Voting Results The following information is provided in accordance with section 251AA(2) of Corporations Act 2001 (Cth) Show of Hands (S) or Poll (P) Resolution Details Resolution Resolution Type If s259U applies S or P 1 Adoption of Remuneration Report Ordinary N/A P 2 Election of Dr Ross Thomas Murdoch as a Director of the Company Ordinary N/A P 3 Election of Mr.Matthew Patrick Mcnamara as a Director of the Company Ordinary N/A P 4 Re-Election of Dr.Gregory Collier as a Director of the Company Ordinary N/A P 5 Approval of the Equity Incentive Plan Ordinary N/A P 6 Approval of Placement Facility Special N/A P 10% Instructions given to validly appointed proxies (as at proxy close) For Against Proxy’s Discretion Abstain/ Excluded For Against Abstain/ Excluded* 452,621,959 4,732,825 5,620,194 24,886,233 471,009,194 4,732,825 24,886,233 97.76% 1.02% 1.22% - 99.01% 0.99% - 479,938,485 2,309,993 4,510,194 1,102,539 512,091,387 2,309,993 11,526,228 98.60% 0.48% 0.92% - 99.55% 0.45% - 478,784,885 1,131,446 6,742,341 1,202,539 513,169,934 1,131,446 11,626,228 98.39% 0.23% 1.38% - 99.78% 0.22% - 480,808,723 1,435,071 4,510,194 1,107,223 512,961,625 1,435,071 11,530,912 98.79% 0.29% 0.92% - 99.72% 0.28% - 277,473,635 112,978,706 5,616,944 91,791,926 283,559,295 125,277,031 91,791,926 70.06% 28.52% 1.42% - 69.36% 30.64% - 455,095,381 22,697,975 5,513,194 4,554,661 487,251,283 22,697,975 14,978,350 94.17% 4.69% 1.14% - 95.55% 4.45% - *Votes cast by a person who abstains on an item are not counted in calculating the required majority on a poll. Avecho Biotechnology Limited | ASX:AVE | ACN: 056 482 403 | ABN: 32 056 482 403 Unit 8A, 2A Westall Road, Hallmarc Business Park, Clayton VIC Australia 3168 Number of votes cast on the poll (where applicable) avecho.com.au Resolution Result Carried/ Not Carried Carried Carried Carried Carried Carried Carried